Emtora Biosciences Email Format
Biotechnology ResearchTexas, United States2-10 Employees
Emtora Biosciences is a small biotechnology research company based in San Antonio, Texas. It is developing eRapa, an encapsulated rapamycin formulation, to prevent the onset and recurrence of cancer. The lead program has advanced to a Phase 1b safety and dosing trial in early-stage prostate cancer patients, with an earlier plan for a pilot efficacy study in Familial Adenomatous Polyposis (FAP) slated for late 2019. The company operates in the biotechnology research industry and pursues clinical development of cancer preventive therapies. In 2024, it signed an exclusive worldwide license with Biodexa Pharmaceuticals to further develop, manufacture, and advance eRapa. The organization is small and focused on advancing its lead program through partnerships and clinical studies.